SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $64,000 | +30.6% | 690 | +9.5% | 0.01% | +33.3% |
| Q2 2021 | $49,000 | -15.5% | 630 | -19.2% | 0.01% | -33.3% |
| Q1 2021 | $58,000 | -32.6% | 780 | +54.2% | 0.01% | -35.7% |
| Q4 2020 | $86,000 | +21.1% | 506 | 0.0% | 0.01% | +16.7% |
| Q3 2020 | $71,000 | -37.2% | 506 | -28.3% | 0.01% | -42.9% |
| Q2 2020 | $113,000 | +63.8% | 706 | 0.0% | 0.02% | +40.0% |
| Q1 2020 | $69,000 | -23.3% | 706 | +0.9% | 0.02% | -6.2% |
| Q4 2019 | $90,000 | +500.0% | 700 | +250.0% | 0.02% | +433.3% |
| Q3 2019 | $15,000 | -50.0% | 200 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $30,000 | +25.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $24,000 | +9.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $22,000 | -72.8% | 200 | -60.0% | 0.01% | -72.7% |
| Q3 2018 | $81,000 | +22.7% | 500 | 0.0% | 0.02% | +15.8% |
| Q2 2018 | $66,000 | +266.7% | 500 | +66.7% | 0.02% | +111.1% |
| Q3 2016 | $18,000 | – | 300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |